يعرض 1 - 20 نتائج من 88 نتيجة بحث عن '"Fetge -- Càncer"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    Academic Journal

    مصطلحات موضوعية: Fetge--Càncer

    وصف الملف: application/pdf

    Relation: Sci Adv. 2024 Jul 12;10(28):eadn3628; info:eu-repo/grantAgreement/EC/HE/101052538; info:eu-repo/grantAgreement/ES/2PE/PID2019-105595GB; info:eu-repo/grantAgreement/ES/3PE/PID2021-122726NB-I00; info:eu-repo/grantAgreement/ES/3PE/PID2021-128791OB-I00; info:eu-repo/grantAgreement/ES/2PE/RTI2018-101759-B-I00; http://hdl.handle.net/10230/61136; http://dx.doi.org/10.1126/sciadv.adn3628

  2. 2
    Academic Journal

    المساهمون: Institut Català de la Salut, Vargas-Accarino E, Higuera M Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Buti M, Mínguez B Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;16(8); https://doi.org/10.3390/cancers16081521; Vargas-Accarino E, Higuera M, Buti M, Mínguez B. Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure. Cancers (Basel). 2024 Apr 16;16(8):1521.; https://hdl.handle.net/11351/11427

  3. 3
    Academic Journal

    المساهمون: Institut Català de la Salut, Serradilla-Martín M Department of Surgery, Hospital Universitario Virgen de las Nieves, Granada, Spain. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. Department of Surgery, School of Medicine, University of Granada, Granada, Spain. Villodre C Department of Surgery, Hospital General Universitario Dr. Balmis, Alicante, Spain. ISABIAL, Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain. Department of Surgery, Universidad Miguel Hernández, Alicante, Spain. Falgueras-Verdaguer L Department of Surgery, Hospital Universitario Dr. Josep Trueta, Girona, Spain. Zambudio-Carroll N Department of Surgery, Hospital Universitario Virgen de las Nieves, Granada, Spain. Castell-Gómez JT Department of Surgery, Hospital Universitario La Paz, Madrid, Spain. Blas-Laina JL Department of Surgery, Hospital Royo Villanova, Zaragoza, Spain. Dopazo C Servei de Cirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;16(9); https://doi.org/10.3390/cancers16091676; Serradilla-Martín M, Villodre C, Falgueras-Verdaguer L, Zambudio-Carroll N, Castell-Gómez JT, Blas-Laina JL, et al. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project). Cancers (Basel). 2024 Apr 26;16(9):1676.; https://hdl.handle.net/11351/11517; 001220644100001

  4. 4
    Academic Journal

    المساهمون: Institut Català de la Salut, Kuiper BI Amsterdam UMC Location Vrije Universiteit Amsterdam, Department of Surgery, De Boelelaan, Amsterdam, the Netherlands. Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands. Abu Hilal M Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy. Aldrighetti LA Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy. Björnsson B Department of Biomedical and Clinical Sciences, Division of Surgery, Linköping University, Linköping, Sweden. D’Hondt M Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium. Dopazo C Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: HPB : the official journal of the International Hepato Pancreato Biliary Association;26(5); https://doi.org/10.1016/j.hpb.2024.01.007; Kuiper BI, Abu Hilal M, Aldrighetti LA, Björnsson B, D’Hondt M, Dopazo C, et al. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases. HPB. 2024 May;26(5):639–47.; https://hdl.handle.net/11351/11482

  5. 5
    Academic Journal

    المساهمون: Institut Català de la Salut, Lopez Lopez V Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, El Palmar, Murcia, Spain. Morise Z Department of Surgery, Fujita Health University School of Medicine Okazaki Medical Center, Okazaki, Aichi, Japan. Albaladejo González M Department of Information and Communication Engineering, Murcia University, Murcia, Spain. Gomez Gavara C, Dalmau M Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Goh BKP, Koh YX Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore. Surgery Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore, Singapore, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Surgical Endoscopy;38; https://doi.org/10.1007/s00464-024-10681-6; Lopez-Lopez V, Morise Z, Albadalejo-González M, Gomez Gavara C, Goh BKP, Koh YX, et al. Explainable artificial intelligence prediction-based model in laparoscopic liver surgery for segments 7 and 8: an international multicenter study. Surg Endosc. 2024 May;38:2411–2422.; https://hdl.handle.net/11351/11473; 001156360600003

  6. 6
    Academic Journal

    المساهمون: Universitat Politècnica de Catalunya. Departament de Teoria del Senyal i Comunicacions, Universitat Politècnica de Catalunya. Departament d'Arquitectura de Computadors, Barcelona Supercomputing Center, Universitat Politècnica de Catalunya. CROMAI - Computing Resources Orchestration and Management for AI

    وصف الملف: application/pdf

    Relation: https://www.sciencedirect.com/science/article/pii/S1361841522003085; Bilic, P. [et al.]. The Liver Tumor Segmentation Benchmark (LiTS). "Medical image analysis", Febrer 2023, vol. 84, article 102680.; http://hdl.handle.net/2117/385213

  7. 7
    Academic Journal

    المساهمون: Institut Català de la Salut, Lim YS Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Chan HLY The Chinese University of Hong Kong, Hong Kong. Ahn SH Yonsei University College of Medicine, Seoul, Republic of Korea. Seto WK University of Hong Kong, Hong Kong. Ning Q Tongji Hospital, Tongji Medical College, Wuhan, China. Agarwal K Institute of Liver Studies, Kings College Hospital, United Kingdom. Buti M Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBEREHD del Instituto Carlos III, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: JHEP Reports;5(10); https://doi.org/10.1016/j.jhepr.2023.100847; Lim YS, Chan HLY, Ahn SH, Seto WK, Ning Q, Agarwal K, et al. Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B. JHEP Rep. 2023 Oct;5(10):100847.; https://hdl.handle.net/11351/10413

  8. 8
    Academic Journal

    المساهمون: Institut Català de la Salut, Calleja-Panero JL Department of Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Esteban Mur R Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Jarque I Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Romero-Gómez M Department of Hepatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Savana Research Group Medsavana and Savana Research S.L., Madrid, Spain. García Labrador L Shionogi S.L.U., Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Gastroenterología y Hepatología;47(3); https://doi.org/10.1016/j.gastrohep.2023.05.010; Calleja-Panero JL, Esteban Mur R, Jarque I, Romero-Gómez M, Savana Research Group, García Labrador L, et al. Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing. Gastroenterol Hepatol. 2024 Mar;47(3):236–45.; https://hdl.handle.net/11351/11169

  9. 9
    Academic Journal

    المساهمون: Institut Català de la Salut, Bracchiglione J Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Viña del Mar, Chile. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Rodríguez-Grijalva G, Requeijo C, Santero M, Salazar J Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. Salas-Gama K CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Direcció de Qualitat, Processos i Innovació, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;15(3); https://doi.org/10.3390/cancers15030766; Bracchiglione J, Rodríguez-Grijalva G, Requeijo C, Santero M, Salazar J, Salas-Gama K, et al. Systemic Oncological Treatments versus Supportive Care for Patients with Advanced Hepatobiliary Cancers: An Overview of Systematic Reviews. Cancers. 2023 Jan 26;15(3):766.; https://hdl.handle.net/11351/9177; 000933088300001

  10. 10
    Academic Journal

    المساهمون: Institut Català de la Salut, Kohansal-Nodehi M, Swiatek-de Lange M, Kroeniger K, Rolny V, Tabarés G Roche Diagnostics GmbH, Research and Development Core Lab, Penzberg, Germany. Piratvisuth T NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand. Esteban JI Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Frontiers in Oncology;13; https://doi.org/10.3389/fonc.2023.1213898; Kohansal-Nodehi M, Swiatek-de Lange M, Kroeniger K, Rolny V, Tabarés G, Piratvisuth T, et al. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. Front Oncol. 2023 Oct 18;13:1213898.; https://hdl.handle.net/11351/10619

  11. 11
    Academic Journal

    المساهمون: Institut Català de la Salut, Wah TM Department of Diagnostic and Interventional Radiology, Institute of Oncology, St. James’s University Hospital, Leeds Teaching Hospitals NHS Trust, UK. Leeds Institute of Medical Research (LIMR), University of Leeds, Leeds, UK. Pech M Department of Interventional Radiology, Universitä tsklinikum Magdeburg, Magdeburg, Germany. Thormann M Clinic for Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany. Serres X Institut de Diagnòstic per la Imatge (IDI), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Littler P, Stenberg B Department of Interventional Radiology, Freeman Hospital, Newcastle Upon Tyne, UK, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: CardioVascular and Interventional Radiology;46; https://doi.org/10.1007/s00270-022-03309-6; Wah TM, Pech M, Thormann M, Serres X, Littler P, Stenberg B, et al. A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER). Cardiovasc Intervent Radiol. 2023 Feb;46:259–67.; https://hdl.handle.net/11351/9025; 000884159600001

  12. 12
    Academic Journal

    المساهمون: Institut Català de la Salut, Higuera M, Torrens M, Torres G Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vargas-Accarino E, Martínez-Campreciós J Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Gregori J Grup de Recerca en Hepatitis Viral, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Salcedo MT Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. Bermúdez-Ramos M Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Bilbao I Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Guerrero-Murillo M Grup de Recerca en Hepatitis Viral, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Serres-Créixams X, Merino X Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Rodríguez-Frías F Servei de Bioquímica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Quer J Grup de Recerca en Hepatitis Viral, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Mínguez B Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Unitat Hepàtica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;14(16); https://doi.org/10.3390/cancers14163875; info:eu-repo/grantAgreement/ES/PE2017-2020/PI18%2F00961; info:eu-repo/grantAgreement/ES/PE2017-2020/PI21%2F00714; info:eu-repo/grantAgreement/ES/PE2013-2016/FI18%2F00027; Higuera M, Vargas-Accarino E, Torrens M, Gregori J, Salcedo MT, Martínez-Campreciós J, et al. Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management. Cancers. 2022 Aug 11;14(16):3875.; https://hdl.handle.net/11351/8415; 000846067900001

  13. 13
    Academic Journal

    المساهمون: Institut Català de la Salut, Gkika E, Grosu AL Department for Radiation Oncology, University Medical Centre Freiburg, Freiburg, Germany. Macarulla Mercade T Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Cubillo Gracián A Department of Medical Oncology, Centro Integral Oncológico Clara Campal HM CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain. Brunner TB Department of Radiotherapy, University Hospital Magdeburg, Magdeburg, Germany. Schultheiß M Department of Medicine II, University Hospital Freiburg, Freiberg, Germany, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;14(6); https://doi.org/10.3390/cancers14061568; Gkika E, Grosu AL, Mercade TM, Gracián AC, Brunner TB, Schultheiß M, et al. Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study. Cancers. 2022 Mar 18;14(6):1568.; https://hdl.handle.net/11351/8372; 000775997000001

  14. 14
    Academic Journal

    المساهمون: Institut Català de la Salut, Piratvisuth T NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand. Tanwandee T Division of Gastroenterology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Thongsawat S Department of Internal Medicine, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, Chiang Mai, Thailand. Sukeepaisarnjaroen W Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand. Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas, Insituto de Salud Carlos III, Madrid, Spain. Esteban JI Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas, Insituto de Salud Carlos III, Madrid, Spain. Bes M Centro de Investigación Biomédica en red de Enfermedades Hepáticas y Digestivas, Insituto de Salud Carlos III, Madrid, Spain. Transfusion Safety Laboratory, Banc de Sang i Teixits, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Hepatology Communications;6(4); https://doi.org/10.1002/hep4.1847; Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, et al. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study. Hepatol Commun. 2022 Apr;6(4):679–91.; https://hdl.handle.net/11351/7741; 000720303500001

  15. 15
    Academic Journal

    المساهمون: Institut Català de la Salut, Malik J, Klammer M, Rolny V Roche Diagnostics GmbH, Penzberg, Germany. Chan HLY Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Piratvisuth T NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Hat Yai, Thailand. Tanwandee T Division of Gastroenterology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Esteban JI Unitat Hepàtica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: World Journal of Gastroenterology;28(29); http://dx.doi.org/10.3748/wjg.v28.i29.3917; Malik J, Klammer M, Rolny V, Chan HLY, Piratvisuth T, Tanwandee T, et al. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2022 Aug 7;28(29):3917–33.; https://hdl.handle.net/11351/8788; 000861051000013

  16. 16
    Academic Journal

    المساهمون: Institut Català de la Salut, Pons M, Manzano R, Bañares J, Bermúdez M Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Rivera-Esteban J Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vargas V, Castells L, Mínguez B Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Digestivas y Hepáticas (CIBERehd), 28029 Madrid, Spain. Salcedo-Allende MT Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Augustin S, Pericàs JM Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Digestivas y Hepáticas (CIBERehd), 28029 Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;11(9); https://doi.org/10.3390/jcm11092466; Pons M, Rivera-Esteban J, Manzano R, Bañares J, Bermúdez M, Vargas V, et al. Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD. J Clin Med. 2022 May;11(9):2466.; https://hdl.handle.net/11351/8050; 000796146700001

  17. 17
    Academic Journal

    المساهمون: Soria A, Casas M Department of Digestive Diseases, Liver Unit, Parc Taulí University Hospital, Investigation and Innovation Institute Parc Taulí I3PT, Universitat Autònoma of Barcelona, Sabadell, Spain. Calvo M, Vidales Z Medical Oncology Department, Catalan Institute of Oncology, Hospitalet, Barcelona, Spain. Muñoz-Martínez S Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Clinical Insitute of Digestive and Metabolic Diseases (ICMDiM), Clinic Hospital, Barcelona University, Barcelona, Spain. Biomedical Research Center in Digestive and Liver Diseases Network (CIBERehd), Instituto Carlos III, Madrid, Spain. Sapena V Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Clinical Insitute of Digestive and Metabolic Diseases (ICMDiM), Clinic Hospital, Barcelona University, Barcelona, Spain. Medical Statistics Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic Barcelona, Barcelona, Spain. Liver Unit, University Hospital Vall d'Hebron, Liver Diseases Research Group, Vall d'Hebron Institut of Research (VHIR), Universitat Autònoma of Barcelona, Barcelona, Spain. Roget M Servei de Malalties Digestives, Unitat Hepàtica, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Frontiers in Oncology;12; https://doi.org/10.3389/fonc.2022.829483; Soria A, Calvo M, Casas M, Vidales Z, Muñoz-Martínez S, Sapena V, et al. Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma. Front Oncol. 2022 Aug 2;12:829483.; https://hdl.handle.net/11351/9921

  18. 18
    Academic Journal

    المساهمون: Institut Català de la Salut, Innominato PF Oncology Department, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, UK. Cancer Research Centre, Warwick Medical School, University of Warwick, Coventry, UK. UPR “Chronotherapy, Cancers and Transplantation”, Faculty of Medicine, Paris-Saclay University, Villejuif, France. Cailliez V, Allard MA AP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Research Unit Chronotherapy, Cancers and Transplantation, University Paris Saclay, Villejuif, France. Lopez-Ben S Hospital Josep Trueta, Girona, Spain. Ferrero A Ospedale Mauriziano Umberto I, Torino, Italy. Marques H Hospital de Curry Cabral, Lisboa, Portugal. Dopazo C Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;14(17); https://doi.org/10.3390/cancers14174340; Innominato PF, Cailliez V, Allard MA, Lopez-Ben S, Ferrero A, Marques H, et al. Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis. Cancers. 2022 Sep 5;14(17):4340.; https://hdl.handle.net/11351/8451; 000851049200001

  19. 19
    Academic Journal

    المساهمون: Institut Català de la Salut, Geynisman DM Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. Burotto M Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile. Porta C Interdisciplinary Department of Medicine, University of Bari ‘A.Moro’ and Division of Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy. Suarez C Servei d’Oncologia Mèdica, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Bourlon MT Department of Hemato-Oncology, Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Huo S Worldwide Health Economics and Outcomes Research-US Market, Bristol Myers Squibb, Princeton, NJ, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Clinical Drug Investigation;42; https://doi.org/10.1007/s40261-022-01170-6; Geynisman DM, Burotto M, Porta C, Suarez C, Bourlon MT, Huo S, et al. Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma. Clin Drug Investig. 2022 Jul;42:611–622.; https://hdl.handle.net/11351/8126; 000810311300001

  20. 20
    Academic Journal

    المساهمون: Institut Català de la Salut, González-Albarrán O Endocrinology and Nutrition Department, Gregorio Marañón Hospital, Madrid, Spain. Morales C Endocrinology and Nutrition Department, Virgen Macarena Hospital, Seville, Spain. Hospital Vithas Sevilla, Seville, Spain. Pérez-Maraver M Endocrinology and Nutrition Unit, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. Aparicio-Sánchez JJ Medical Affairs Department, AstraZeneca Farmacéutica Spain, Madrid, Spain. Simó R Diabetes and Metabolism Research Group, VHIR, Endocrinology Department, Vall d’Hebron University Hospital, Autonomous University Barcelona, 08035, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Diabetes Therapy;13(Supl 1); https://doi.org/10.1007/s13300-022-01276-2; González-Albarrán O, Morales C, Pérez-Maraver M, Aparicio-Sánchez JJ, Simó R. Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D. Diabetes Ther. 2022 Jul;13(Suppl 1):35–49.; https://hdl.handle.net/11351/8140; 000811438400003